Trials / Completed
CompletedNCT01613456
Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome
Effect of S.Cerevisiae vs Placebo on the Improvement of Gastrointestinal Disorders,Especially During Irritable Bowel Syndrome. Randomized, Double-blind Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 364 (actual)
- Sponsor
- Lesaffre International · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is the effect of the probiotic yeast Saccharomyces cerevisiae CNCM I-3856 on abdominal pain or intestinal discomfort in patients presenting with the irritable bowel syndrome (IBS)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Saccharomyces cerevisiae CNCM I-3856 | 2 capsules/day during 12 weeks |
| DIETARY_SUPPLEMENT | Placebo | Capsule with comparable organoleptic properties and weight than the experimental product. 2 capsules/day during 12 weeks |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-06-07
- Last updated
- 2015-05-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01613456. Inclusion in this directory is not an endorsement.